Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

11.29
Delayed Data
As of 3:58pm ET
 +0.01 / +0.09%
Today’s Change
8.10
Today|||52-Week Range
16.54
-12.34%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close11.28
Today’s open11.44
Day’s range10.86 - 11.55
Volume27,022
Average volume (3 months)40,435
Market cap$144.2M
Dividend yield--
Data as of 3:58pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-60.54%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.96%
P/E ratio--
Price/Sales47,981.20
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
ZYNEZynerba Pharmaceutic...+1.02+7.03%
GLYCGlycoMimetics Inc-0.04-0.64%
VVUSVIVUS Inc+0.01+0.72%
XENEXenon Pharmaceutical...-0.10-1.27%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$3.0K
Annual profit (last year)-$21.1M
Net profit margin-703,000.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs